Hercules Technology Growth Capital Inc. expects a net gain of about $2.2 million to $2.3 million in the first quarter of 2012 and a full repayment of its loan to Barrx Medical Inc., one of its portfolio companies.
Earlier this month, Hercules completed the sale of all its outstanding shares of Sunnyvale-based Barrx to Covidien plc (NYSE:COV) in a deal valued at $325 million.
No comments:
Post a Comment